Inspire Investing’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,320
Closed -$1.32M 868
2023
Q2
$1.32M Buy
9,320
+444
+5% +$71.2K 0.16% 154
2023
Q1
$1.49M Buy
8,876
+713
+9% +$127K 0.19% 112
2022
Q4
$1.38M Buy
8,163
+1,320
+19% +$239K 0.18% 121
2022
Q3
$1.28M Buy
+6,843
New +$1.44M 0.18% 112
2021
Q2
Sell
-2,948
Closed -$573K 614
2021
Q1
$573K Buy
2,948
+1,198
+68% +$246K 0.09% 231
2020
Q4
$335K Buy
+1,750
New +$318K 0.07% 383

Other funds holding RGEN

Inspire Investing's RGEN Position: Q3 2023 in Review

Inspire Investing sold out of Repligen (RGEN) in Q3 2023, closing a stake of 9,320 shares — an estimated $1.32M sold.

Inspire Investing first reported a position in RGEN in Q4 2020 and held it in 6 quarters. The position peaked at $1.49M in Q1 2023. 439 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.

  • Inspire Investing reported no remaining Repligen position as of Q3 2023 after selling out during the quarter.
  • Inspire Investing sold 9,320 Repligen shares in Q3 2023, an estimated $1.32M.
  • Inspire Investing first reported a position in Repligen in Q4 2020 and held it in 6 quarters.
  • Inspire Investing's Repligen position peaked at $1.49M in Q1 2023.
  • 439 funds tracked by Wall St. Rank held Repligen as of Q3 2023.

Based on Inspire Investing's 13F filing for Q3 2023, filed 26 Oct 2023.